NADMED raises €3.5m to boost a new testing technology for NAD and glutathione
Silicon Canals - 22-Aug-2024The funds will help expand their market reach, particularly into the US
Anu Suomalainen-Wartiovaara
Professor of Clinical Molecular Medicine at Faculty of Medicine, University of Helsinki
Anu Suomalainen Wartiovaara gained an MD and PhD at the University of Helsinki and did postdoctoral research at the National Public Health Institute, Helsinki, and McGill University, Montreal. In 2001, she became a group leader at Biomedicum-Helsinki. She is currently Sigrid Jusélius professor of clinical molecular medicine at the University of Helsinki, and her group focuses on the molecular basis and treatment of mitochondrial disorders.
See also: 
University of Helsinki
- Multidisciplinary research university.
Details last updated 18-May-2020
Anu Suomalainen-Wartiovaara is also referenced in the following:
ARDD 2022 - 9th Aging Research and Drug Discovery Meeting
29-Aug-2022 to 02-Sep-2022
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Anu Suomalainen-Wartiovaara News
Vitamin B3 is a good option to correct the NAD+ deficit in humans
Phys.org - 14-May-2020NAD+ deficiency is for real and it happens in humans too
